AAAAAA

   
Results: 1-25 | 26-50 | 51-73
Results: 26-50/73
LUPUS ANTICOAGULANT AND THROMBOEMBOLISM - EVALUATION OF FIBRINOGEN, NATURAL INHIBITORS AND MOLECULAR MARKERS OF THROMBOSIS
Authors: GSCHWANDTNER ME EICHINGER S HUTTER D KORNINGER L LECHNER K PANZER S PABINGER I
Citation: Me. Gschwandtner et al., LUPUS ANTICOAGULANT AND THROMBOEMBOLISM - EVALUATION OF FIBRINOGEN, NATURAL INHIBITORS AND MOLECULAR MARKERS OF THROMBOSIS, Blood coagulation & fibrinolysis, 7(3), 1996, pp. 325-330
FLAG (FLUDARABINE, CYTOSINE-ARABINOSIDE, G-CSF) FOR REFRACTORY AND RELAPSED ACUTE MYELOID-LEUKEMIA
Authors: HUHMANN IM WATZKE HH GEISSLER K GISSLINGER H JAGER U KNOBL P PABINGER I KORNINGER L MANNHALTER C MITTERBAUER G SCHWARZINGER I KALHS P HAAS OA LECHNER K
Citation: Im. Huhmann et al., FLAG (FLUDARABINE, CYTOSINE-ARABINOSIDE, G-CSF) FOR REFRACTORY AND RELAPSED ACUTE MYELOID-LEUKEMIA, Annals of hematology, 73(6), 1996, pp. 265-271
SPONTANEOUS REMISSION OF ACUTE MYELOID-LEUKEMIA AFTER INFECTION AND BLOOD-TRANSFUSION ASSOCIATED WITH HYPERGAMMAGLOBULINEMIA
Authors: MITTERBAUER M FRITZERSZEKERES M MITTERBAUER G SIMONITSCH I KNOBL P RINTELEN C SCHWARZINGER I HAAS OA SILBERBAUER K FREY K BIBUS B PABINGER I RADASZKIEWICZ T LECHNER K JAEGER U
Citation: M. Mitterbauer et al., SPONTANEOUS REMISSION OF ACUTE MYELOID-LEUKEMIA AFTER INFECTION AND BLOOD-TRANSFUSION ASSOCIATED WITH HYPERGAMMAGLOBULINEMIA, Annals of hematology, 73(4), 1996, pp. 189-193
DURATION OF 2ND COMPLETE REMISSION IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH CHEMOTHERAPY - A RETROSPECTIVE SINGLE-CENTER STUDY
Authors: THALHAMMER F GEISSLER K JAGER U KYRLE PA PABINGER I MITTERBAUER M GISSLINGER H KNOBL P LACZIKA K SCHNEIDER B HAAS OA LECHNER K
Citation: F. Thalhammer et al., DURATION OF 2ND COMPLETE REMISSION IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH CHEMOTHERAPY - A RETROSPECTIVE SINGLE-CENTER STUDY, Annals of hematology, 72(4), 1996, pp. 216-222
RESISTANCE TO ACTIVATED PROTEIN-C (APC) - MUTATION AT ARG(506) OF COAGULATION-FACTOR-V AND VASCULAR ACCESS THROMBOSIS IN HEMODIALYSIS-PATIENTS
Authors: FODINGER M MANNHALTER C PABINGER I KOIZAR D RINTELEN C HORL WH SUNDERPLASSMANN G
Citation: M. Fodinger et al., RESISTANCE TO ACTIVATED PROTEIN-C (APC) - MUTATION AT ARG(506) OF COAGULATION-FACTOR-V AND VASCULAR ACCESS THROMBOSIS IN HEMODIALYSIS-PATIENTS, Nephrology, dialysis, transplantation, 11(4), 1996, pp. 668-672
2 NEW FREQUENT DIMORPHISMS IN THE PROTEIN-S (PROS1) GENE
Authors: MUSTAFA S PABINGER I MANNHALTER C
Citation: S. Mustafa et al., 2 NEW FREQUENT DIMORPHISMS IN THE PROTEIN-S (PROS1) GENE, Thrombosis and haemostasis, 76(3), 1996, pp. 393-396
NO INCREASED PREVALENCE OF THE FACTOR-V LEIDEN MUTATION IN CHRONIC MAJOR VESSEL THROMBOEMBOLIC PULMONARY-HYPERTENSION (CTEPH)
Authors: LANG IM KLEPETKO W PABINGER I
Citation: Im. Lang et al., NO INCREASED PREVALENCE OF THE FACTOR-V LEIDEN MUTATION IN CHRONIC MAJOR VESSEL THROMBOEMBOLIC PULMONARY-HYPERTENSION (CTEPH), Thrombosis and haemostasis, 76(3), 1996, pp. 476-477
FACTOR-V ENHANCES THE COFACTOR FUNCTION OF PROTEIN-S IN THE APC-MEDIATED INACTIVATION OF FACTOR-VIII - INFLUENCE OF THE FACTOR V-R506Q MUTATION
Authors: VARADI K ROSING J TANS G PABINGER I KEIL B SCHWARZ HP
Citation: K. Varadi et al., FACTOR-V ENHANCES THE COFACTOR FUNCTION OF PROTEIN-S IN THE APC-MEDIATED INACTIVATION OF FACTOR-VIII - INFLUENCE OF THE FACTOR V-R506Q MUTATION, Thrombosis and haemostasis, 76(2), 1996, pp. 208-214
PROBABILITY OF RECURRENCE OF THROMBOSIS IN PATIENTS WITH AND WITHOUT FACTOR-V LEIDEN
Authors: RINTELEN C PABINGER I KNOBL P LECHNER K MANNHALTER C
Citation: C. Rintelen et al., PROBABILITY OF RECURRENCE OF THROMBOSIS IN PATIENTS WITH AND WITHOUT FACTOR-V LEIDEN, Thrombosis and haemostasis, 75(2), 1996, pp. 229-232
ORAL ANTICOAGULANTS AND FETAL LOSS
Authors: RINTELEN C MANNHALTER C PABINGER I SCHARRER I KLINKE S
Citation: C. Rintelen et al., ORAL ANTICOAGULANTS AND FETAL LOSS, Lancet, 348(9043), 1996, pp. 1735-1735
INCREASED FETAL LOSS IN WOMEN WITH HERITABLE THROMBOPHILIA
Authors: PRESTON FE ROSENDAAL FR WALKER ID BRIET E BERNTORP E CONARD J FONTCUBERTA J MAKRIS M MARIANI G NOTEBOOM W PABINGER I LEGNANI C SCHARRER I SCHULMAN S VANDERMEER FJM
Citation: Fe. Preston et al., INCREASED FETAL LOSS IN WOMEN WITH HERITABLE THROMBOPHILIA, Lancet, 348(9032), 1996, pp. 913-916
THROMBOTIC TENDENCY IN 75 SYMPTOMATIC, UNRELATED PATIENTS WITH APC RESISTANCE
Authors: MELICHART M KYRLE PA EICHINGER S RINTELEN C MANNHALTER C PABINGER I
Citation: M. Melichart et al., THROMBOTIC TENDENCY IN 75 SYMPTOMATIC, UNRELATED PATIENTS WITH APC RESISTANCE, Wiener Klinische Wochenschrift, 108(19), 1996, pp. 607-610
ORAL-CONTRACEPTIVES ENHANCE THE RISK OF CLINICAL MANIFESTATION OF VENOUS THROMBOSIS AT A YOUNG AGE IN FEMALES HOMOZYGOUS FOR FACTOR-V LEIDEN
Authors: RINTELEN C MANNHALTER C IRELAND H LANE DA KNOBL P LECHNER K PABINGER I
Citation: C. Rintelen et al., ORAL-CONTRACEPTIVES ENHANCE THE RISK OF CLINICAL MANIFESTATION OF VENOUS THROMBOSIS AT A YOUNG AGE IN FEMALES HOMOZYGOUS FOR FACTOR-V LEIDEN, British Journal of Haematology, 93(2), 1996, pp. 487-490
IDENTIFICATION OF 2 FREQUENT DIMORPHISMS IN THE PROTEIN-S GENE
Authors: MANNHALTER C MUSTAFA S PABINGER I
Citation: C. Mannhalter et al., IDENTIFICATION OF 2 FREQUENT DIMORPHISMS IN THE PROTEIN-S GENE, Blood, 88(10), 1996, pp. 2999-2999
HOMOZYGOUS C-]T MUTATION IN THE METHYLENE TETRAHYDROFOLATE REDUCTASE (MTHFR) GENE DOES NDT INCREASE THE RISK FOR VENOUS THROMBOSIS IN PATIENTS WITH THE FACTOR-V LEIDEN MUTATION
Authors: RINTELEN C PABINGER I LECHNER K EICHINGER S KYRLE PA MANNHALTER C
Citation: C. Rintelen et al., HOMOZYGOUS C-]T MUTATION IN THE METHYLENE TETRAHYDROFOLATE REDUCTASE (MTHFR) GENE DOES NDT INCREASE THE RISK FOR VENOUS THROMBOSIS IN PATIENTS WITH THE FACTOR-V LEIDEN MUTATION, Blood, 88(10), 1996, pp. 3007-3007
A SINGLE GENETIC-ORIGIN FOR THE COMMON CAUCASIAN FACTOR-V MUTATION PREDISPOSING TO THROMBOSIS
Authors: ZIVELIN A GRIFFIN JH XU X PABINGER I SAMAMA M CONARD J BRENNER B ELDOR A SELIGSOHN U
Citation: A. Zivelin et al., A SINGLE GENETIC-ORIGIN FOR THE COMMON CAUCASIAN FACTOR-V MUTATION PREDISPOSING TO THROMBOSIS, Blood, 88(10), 1996, pp. 1123-1123
ERRONEOUSLY LOW APC RATIO IN PATIENTS WITH LUPUS ANTICOAGULANT
Authors: GSCHWANDTNER ME LECHNER K PABINGER I
Citation: Me. Gschwandtner et al., ERRONEOUSLY LOW APC RATIO IN PATIENTS WITH LUPUS ANTICOAGULANT, Annals of hematology, 70(3), 1995, pp. 169-170
ELIMINATION OF ACQUIRED FACTOR-VIII ANTIBODIES BY EXTRACORPOREAL ANTIBODY-BASED IMMUNOADSORPTION (IG-THERASORB(R))
Authors: KNOBL P DERFLER K KORNINGER L KAPIOTIS S JAGER U MAIERDOBERSBERGER T HORL W LECHNER K PABINGER I
Citation: P. Knobl et al., ELIMINATION OF ACQUIRED FACTOR-VIII ANTIBODIES BY EXTRACORPOREAL ANTIBODY-BASED IMMUNOADSORPTION (IG-THERASORB(R)), Thrombosis and haemostasis, 74(4), 1995, pp. 1035-1038
THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM (VTE) - THE PREDICTIVE VALUE OF DETERMINATION OF ACTIVATED PROTEIN-C (APC) - RESISTANCE AND OF MONITORING MOLECULAR MARKERS OF THROMBOSIS
Authors: EICHINGER S PABINGER I SCHNEIDER B STUMPFLEN A HIRSCHL C BIALONCZYK C MELICHART M RINTELEN C LECHNER K KYRTE PA
Citation: S. Eichinger et al., THE RISK OF RECURRENCE OF VENOUS THROMBOEMBOLISM (VTE) - THE PREDICTIVE VALUE OF DETERMINATION OF ACTIVATED PROTEIN-C (APC) - RESISTANCE AND OF MONITORING MOLECULAR MARKERS OF THROMBOSIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1091-1091
CLINICAL-FEATURE IN PATIENTS WITH HOMOZYGOUS AND HETEROZYGOUS FACTOR-V LEIDEN MUTATION (APC-RESISTANCE) AND A HISTORY OF VENOUS THROMBOEMBOLISM
Authors: RINTELEN C BAYSTON TA IRELAND H LANE DA MANNHALTER C PABINGER I
Citation: C. Rintelen et al., CLINICAL-FEATURE IN PATIENTS WITH HOMOZYGOUS AND HETEROZYGOUS FACTOR-V LEIDEN MUTATION (APC-RESISTANCE) AND A HISTORY OF VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 73(6), 1995, pp. 1124-1124
THE COMBINED EFFECT OF PURIFIED FACTOR-V AND PROTEIN-S ON THE APC-MEDIATED INACTIVATION OF FACTOR VIIIA
Authors: VARADI K KEIL B ROSING J TANS G PABINGER I SCHWARZ HP
Citation: K. Varadi et al., THE COMBINED EFFECT OF PURIFIED FACTOR-V AND PROTEIN-S ON THE APC-MEDIATED INACTIVATION OF FACTOR VIIIA, Thrombosis and haemostasis, 73(6), 1995, pp. 1259-1259
FACTOR-V LEIDEN AS AN INDEPENDENT RISK FACTOR FOR THROMBOSIS IN ANTITHROMBIN DEFICIENCY TYPE-II - HEPARIN-BINDING SITE
Authors: IRELAND H BAYSTON TA CHOWDHURY V THEIN SL CONARD J PABINGER I LANE DA
Citation: H. Ireland et al., FACTOR-V LEIDEN AS AN INDEPENDENT RISK FACTOR FOR THROMBOSIS IN ANTITHROMBIN DEFICIENCY TYPE-II - HEPARIN-BINDING SITE, Thrombosis and haemostasis, 73(6), 1995, pp. 1361-1361
FACTOR-V (FV) LEIDEN MUTATION (APC-RESISTANCE) INCREASES THE RISK FORVENOUS THROMBOEMBOLISM IN PATIENTS WITH A GENE DEFECT OF THE PROTEIN-C (PC) OR PROTEIN-S (PS) GENE
Authors: PABINGER I MUSTAFA S RINTELEN C KYRLE PA LECHNER K MANNHALTER C
Citation: I. Pabinger et al., FACTOR-V (FV) LEIDEN MUTATION (APC-RESISTANCE) INCREASES THE RISK FORVENOUS THROMBOEMBOLISM IN PATIENTS WITH A GENE DEFECT OF THE PROTEIN-C (PC) OR PROTEIN-S (PS) GENE, Thrombosis and haemostasis, 73(6), 1995, pp. 1361-1361
FACTOR-V LEIDEN IS NOT A PREDICTIVE PARAMETER FOR RECURRENT THROMBOSIS IN PATIENTS (PTS) WITH A HISTORY OF VENOUS THROMBOSIS (VT)
Authors: RINTELEN C KNOBL P OVISSI L PABINGER I MANNHALTER C
Citation: C. Rintelen et al., FACTOR-V LEIDEN IS NOT A PREDICTIVE PARAMETER FOR RECURRENT THROMBOSIS IN PATIENTS (PTS) WITH A HISTORY OF VENOUS THROMBOSIS (VT), Thrombosis and haemostasis, 73(6), 1995, pp. 1371-1371
ELIMINATION OF ACQUIRED INHIBITORS TO FACTOR-VIII AND FACTOR-V WITH IMMUNOSPECIFIC IMMUNOGLOBULIN APHERESIS
Authors: KNOBL P DERFLER K KORNINGER L KAPIOTIS S JAGER U MAIENDOBERSBERGER T TRIBL B SPEISER W DRUML W PABINGER I LECHNER K
Citation: P. Knobl et al., ELIMINATION OF ACQUIRED INHIBITORS TO FACTOR-VIII AND FACTOR-V WITH IMMUNOSPECIFIC IMMUNOGLOBULIN APHERESIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1423-1423
Risultati: 1-25 | 26-50 | 51-73